445 related articles for article (PubMed ID: 2107521)
61. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. The Collaborative Study Group.
Holmes SJ; Lucas AH; Osterholm MT; Froeschle JE; Granoff DM
JAMA; 1991 Oct; 266(14):1960-5. PubMed ID: 1895474
[TBL] [Abstract][Full Text] [Related]
62. Immunogenicity and safety of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis conjugate vaccine in 7.5 micrograms liquid formulation: a comparison of three lots with the 15.0 micrograms lyophilized formulation. Study Group for 7.5 micrograms Liquid PedvaxHIB.
Mendelman PM; Feeley L; Bird S; Staub T; Matthews H; Del Beccaro MA; Overturf G; Lee A; Ellis R; Staub J; Szymanski S; Donnelly J; Hennessey JP; Kniskern P
Vaccine; 1997; 15(6-7):775-81. PubMed ID: 9178481
[TBL] [Abstract][Full Text] [Related]
63. Responses of children to booster immunization with their primary conjugate Haemophilus influenzae type B vaccine or with polyribosylribitol phosphate conjugated with diphtheria toxoid.
Decker MD; Edwards KM; Bradley R; Palmer P
J Pediatr; 1993 Mar; 122(3):410-3. PubMed ID: 8441096
[TBL] [Abstract][Full Text] [Related]
64. Antibody responses of black children to Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein conjugate vaccine in relation to the Km(1) allotype.
Lenoir AA; Pandey JP; Granoff DM
J Infect Dis; 1988 Jun; 157(6):1242-5. PubMed ID: 3131441
[No Abstract] [Full Text] [Related]
65. Distribution and excretion of capsular antigen after immunization with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
Sood SK; Ballanco GA; Mather FJ; Pramberg JC; Daum RS
J Infect Dis; 1990 Mar; 161(3):574-7. PubMed ID: 2107266
[TBL] [Abstract][Full Text] [Related]
66. Anti-PRP antibody levels after a primary series of PRP-OMPC and persistence of antibody titres following primary and booster doses.
Calandra GB; Lukacs LJ; Jonas LC; Santosham M; Ward JI; Greenberg DP; Daum RS; Matthews H; Vella PP; Ryan JL
Vaccine; 1993; 11 Suppl 1():S58-62. PubMed ID: 8447178
[TBL] [Abstract][Full Text] [Related]
67. Vaccination of 18-month-old children with conjugated polyribosyl ribitol phosphate stimulates production of functional antibody to Haemophilus influenzae type b.
Musher DM; Watson DA; Lepow ML; McVerry P; Hamill R; Baughn RE
Pediatr Infect Dis J; 1988 Mar; 7(3):156-9. PubMed ID: 3258660
[TBL] [Abstract][Full Text] [Related]
68. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
Blanchard-Rohner G; Pollard AJ
Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987
[TBL] [Abstract][Full Text] [Related]
69. Differing serologic responses to an haemophilus influenzae type b polysaccharide-neisseria meningitidis outer membrane protein conjugate (PRP-OMPC) vaccine in australian aboriginal and caucasian infants - implications for disease epidemiology.
Guthridge S; McIntyre P; Isaacs D; Hanlon M; Patel M
Vaccine; 2000 May; 18(23):2584-91. PubMed ID: 10775792
[TBL] [Abstract][Full Text] [Related]
70. Safety and immunogenicity of a conjugated Haemophilus influenzae type B polysaccharide-Neisseria meningitidis outer membrane protein vaccine.
Yeh SJ; Huang LM; Chen JM; Lee PI; Chang LY; Lin YJ; Chiu HH; Lee CY
J Formos Med Assoc; 1997 Feb; 96(2):110-5. PubMed ID: 9071836
[TBL] [Abstract][Full Text] [Related]
71. Interim report of a controlled field trial of immunization with capsular polysaccharides of Haemophilus influenzae type b and group C Neisseria meningitidis in Mecklenburg county, North Carolina (March 1974-March 1976).
Parke JC; Schneerson R; Robbins JB; Schlesselman JJ
J Infect Dis; 1977 Aug; 136 Suppl():S51-6. PubMed ID: 408433
[TBL] [Abstract][Full Text] [Related]
72. Immunization after invasive Haemophilus influenzae type b disease. Serologic response to a conjugate vaccine.
Edwards KM; Decker MD; Porch CR; Palmer P; Bradley R
Am J Dis Child; 1989 Jan; 143(1):31-3. PubMed ID: 2783356
[TBL] [Abstract][Full Text] [Related]
73. Response of MUTZ-3 dendritic cells to the different components of the Haemophilus influenzae type B conjugate vaccine: towards an in vitro assay for vaccine immunogenicity.
Hoefnagel MH; Vermeulen JP; Scheper RJ; Vandebriel RJ
Vaccine; 2011 Jul; 29(32):5114-21. PubMed ID: 21624423
[TBL] [Abstract][Full Text] [Related]
74. Prevention of Haemophilus influenzae type b infections in Apache and Navajo children.
Santosham M; Rivin B; Wolff M; Reid R; Newcomer W; Letson GW; Almeido-Hill J; Thompson C; Siber GR
J Infect Dis; 1992 Jun; 165 Suppl 1():S144-51. PubMed ID: 1588150
[TBL] [Abstract][Full Text] [Related]
75. Comparative immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines.
Granoff DM; Holmes SJ
Vaccine; 1991 Jun; 9 Suppl():S30-4; discussion S42-3. PubMed ID: 1891954
[TBL] [Abstract][Full Text] [Related]
76. Restricted Ig H chain V gene usage in the human antibody response to Haemophilus influenzae type b capsular polysaccharide.
Adderson EE; Shackelford PG; Quinn A; Carroll WL
J Immunol; 1991 Sep; 147(5):1667-74. PubMed ID: 1908880
[TBL] [Abstract][Full Text] [Related]
77. Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use.
Black SB; Shinefield HR; Fireman B; Hiatt R
J Infect Dis; 1992 Jun; 165 Suppl 1():S139-43. PubMed ID: 1588149
[TBL] [Abstract][Full Text] [Related]
78. Duration of serum anticapsular antibody after a two-dose regimen of a Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine and anamnestic response after a third dose.
Sood SK; Ballanco GA; Daum RS
J Pediatr; 1991 Oct; 119(4):652-4. PubMed ID: 1919901
[No Abstract] [Full Text] [Related]
79. Anti-polyribosyl-ribitol phosphate and anti-N. meningitidis outer membrane protein antibody levels following PRP-OMP conjugate vaccination.
Wong VK; Kim KS
Vaccine; 1993; 11(9):979-80. PubMed ID: 8212847
[No Abstract] [Full Text] [Related]
80. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
Siber GR; Thompson C; Reid GR; Almeido-Hill J; Zacher B; Wolff M; Santosham M
J Infect Dis; 1992 Jun; 165 Suppl 1():S129-33. PubMed ID: 1588146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
